Opyl Ltd. (AU:OPL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Opyl Limited has entered a strategic service agreement with Commercial Eyes, a leading Australian consultancy in the pharmaceutical and medical device sector. This partnership will allow Opyl to provide AI-driven market research and competitive intelligence, enhancing Commercial Eyes’ capabilities in the global market, particularly in the JAPAC region. The collaboration is expected to strengthen Opyl’s market presence both domestically and internationally.
For further insights into AU:OPL stock, check out TipRanks’ Stock Analysis page.